$23.46
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NYSE:AORT
Artivion Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | NYSE | Outperform | $104.09 | $118.92 | 0.00% | 7 | $181.08B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| MDT | Medtronic | NYSE | Outperform | $85.92 | $92.47 | 0.00% | 9 | $114.09B |
| BSX | Boston Scientific | NYSE | Buy | $74.65 | $70.14 | 0.00% | 6 | $109.75B |
| BDX | Becton Dickinson and Co | NYSE | Outperform | $236.30 | $284.47 | 0.00% | 8 | $68.29B |
| EW | Edwards Lifesciences Corp | NYSE | Outperform | $89.14 | $91.18 | 0.00% | 5 | $53.72B |
| 4543 | Terumo | TSE | Outperform | ¥5.63k | ¥4.97k | 0.00% | 0 | ¥3.76T |
| BAX | Baxter International Inc | NYSE | Hold | $35.25 | $44.86 | 0.00% | 5 | $17.96B |
| SWAV | Shockwave Medical | NasdaqGS | Hold | $330.13 | $239.91 | 0.00% | 6 | $12.41B |
| PEN | Penumbra | NYSE | Outperform | $203.53 | $258.62 | 0.00% | 14 | $8.12B |
| GETI B | Getinge AB | OM | Outperform | kr185.50 | kr226.10 | 0.00% | 3 | kr63.33B |
| MMSI | Merit Medical Systems | NasdaqGS | Outperform | $81.89 | $89.25 | 0.00% | 0 | $4.65B |
| 688016 | Shanghai MicroPort Endovascula... | SHSE | Buy | ¥122.98 | ¥238.98 | 0.00% | 0 | ¥15.42B |
| IART | Integra LifeSciences Holdings | NasdaqGS | Hold | $27.54 | $46.60 | 0.00% | 4 | $1.82B |
| LMAT | LeMaitre Vascular | NasdaqGM | Outperform | $78.45 | $59.86 | 0.00% | 0 | $1.45B |
| ATRC | AtriCure | NasdaqGM | Buy | $23.14 | $55.00 | 0.00% | 6 | $1.17B |
| 1302 | LifeTech Scientific | SEHK | Buy | HK$1.93 | HK$2.97 | 0.00% | 0 | HK$8.94B |
| SILK | Silk Road Medical, Inc | NasdaqGS | Outperform | $22.18 | $12.33 | 0.00% | 4 | $824.34M |
| AVR | Anteris Technologies Ltd | ASX | Buy | $19.61 | $28.00 | 0.00% | 0 | $408.99M |
| ANGO | AngioDynamics | NasdaqGS | Buy | $6.04 | $16.33 | 0.00% | 0 | $231.92M |
| ELUT | Elutia | NasdaqCM | Buy | $3.94 | $0.00 | 0.00% | 0 | $78.32M |
| RUA | RUA Life Sciences | AIM | £0.11 | £0.66 | 0.00% | 0 | £6.83M | |
| AVGR | Avinger | NasdaqCM | Outperform | $3.58 | $5.00 | 0.00% | 0 | $6.09M |
